Apricus Biosciences Inc (NASDAQ:APRI) shares are rising by 3% in Thursday’s trading on the news that Apricus has completed the sale to …
VIVUS, Inc. (NASDAQ:VVUS) investors celebrate a 14% gain in the stock this morning, after the company announced an agreement providing Metuchen Pharmaceuticals a fully-paid, …
In a research report published Thursday, Needham analyst Alan Carr reiterated a Hold rating on VIVUS, Inc. (NASDAQ:VVUS), as the company is expected to announce …
Brean Capital analyst Jonathan Aschoff reiterated a Sell rating on Vivus (NASDAQ:VVUS), while keeping his price target at $4, which represents a potential upside of 18% from …
